“A one-on one-off approach to future medicines funding is a slippery slope to a NZ Pharmac for Australia, that cannot be allowed to happen," said Better Access Australia chair Felicity McNeill PSM. …
'HTA review will achieve savings, but it won’t achieve better access for all'
September 12, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Algorae signs two-part deal with Umedica to expand Australian portfolio
October 19, 2026 - - Latest News -
Novartis, Boehringer Ingelheim leaders join Medicines Australia board
October 19, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5. Ep.36
October 19, 2026 - - Podcast -
Cancer physicians now running communication skills workshops on how to discuss private pay
October 19, 2026 - - Latest News -
'If your doctor prescribes it, it should be covered,' pollster recommends as the key message
October 19, 2026 - - Latest News -
Global headwinds and new contenders set the agenda for Australia's 'Biggest Week in Biotech'
October 19, 2026 - - Latest News -
Mixed PBAC outcomes for multi-cancer immunotherapy listings
October 19, 2026 -